Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Juvenile Idiopathic Arthritis
• Polymyalgia Rheumatica
• Psoriatic Arthritis
• Spondyloarthritis
• Systemic Lupus Erythematosus
• Systemic Sclerosis
• Systemic Vasculitis

Drugs mentioned

• Herpes Zoster Vaccine (herpes zoster vaccine)

Snippet

Sponsor: Region Skane | Conditions: Systemic Vasculitis, Spondylarthropathies | Phase 4 | Status: ENROLLING_BY_INVITATION